Education
About Us
Working with TipRanks
Follow Us
Matthew Strobeck Insider Profile
11 Followers
Matthew Strobeck, Director at Yield10 Bioscience, holds 82.55K shares in QuidelOrtho (Ticker: QDEL), holds 5.76M shares in Biodesix (Ticker: BDSX), holds 325.24K shares in Accelerate Diagnostics (Ticker: AXDXQ). Most recently, Matthew Strobeck Bought ― shares of QuidelOrtho on Feb 13, 2026 for an estimated value of $239.50K.
Profitable Transactions
8 out of 16 Profitable Transactions
Average Return
-4.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Strobeck holds in companies
Most Profitable Insider Trade
Stock:
Accelerate Diagnostics
(AXDXQ)
(AXDXQ)
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+101.00%
The most profitable trade made by Matthew Strobeck
Matthew Strobeck's Trading History
Yield10 Bioscience
Jan 28, 2016
Director
Uninformative Sell
―
$34.27K
Accelerate Diagnostics
Jan 25, 2024
―
Uninformative Buy
―
$3.25K
QuidelOrtho
Feb 13, 2026
Director
Informative Buy
239.50K
$1.81M
Biodesix
Nov 06, 2024
Director
Informative Buy
55.60K
$74.95M
Santarus
Apr 10, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Matthew Strobeck's performance on stock
You May Also Like
Matthew Strobeck insider profile FAQ
What is the percentage of profitable transactions made by Matthew Strobeck?
The percentage of profitable transactions made by Matthew Strobeck is 50%.
What is the average return per transaction made by Matthew Strobeck?
The average return per transaction made by Matthew Strobeck is -4.80%.
What stocks does Matthew Strobeck hold?
Matthew Strobeck holds: YTENQ, AXDXQ, QDEL, BDSX, SNTS stocks.
What was Matthew Strobeck’s latest transaction?
Matthew Strobeck latest transaction was an Informative Buy of $239.50K.
What was Matthew Strobeck's most profitable transaction?
Matthew Strobeck’s most profitable transaction was an Informative Buy of AXDXQ stock on March 20, 2020. The return on the trade was 101.00%.
What is Matthew Strobeck's role in Yield10 Bioscience?
Matthew Strobeck's role in Yield10 Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.